Göknur Kara

756 total citations · 1 hit paper
20 papers, 511 citations indexed

About

Göknur Kara is a scholar working on Molecular Biology, Biomaterials and Cancer Research. According to data from OpenAlex, Göknur Kara has authored 20 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Biomaterials and 6 papers in Cancer Research. Recurrent topics in Göknur Kara's work include RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (8 papers) and Nanoparticle-Based Drug Delivery (6 papers). Göknur Kara is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (8 papers) and Nanoparticle-Based Drug Delivery (6 papers). Göknur Kara collaborates with scholars based in Türkiye, United States and Spain. Göknur Kara's co-authors include Bülent Özpolat, George A. Călin, Emir Baki Denkbaş, Feray Bakan, Murat Cokol, Banu Arun, Ömer Bayır, Ferda Alpaslan Pınarlı, Mehmet Hakan Korkmaz and Mustafa Türk and has published in prestigious journals such as Cancer Research, Advanced Drug Delivery Reviews and Colloids and Surfaces A Physicochemical and Engineering Aspects.

In The Last Decade

Göknur Kara

20 papers receiving 502 citations

Hit Papers

RNAi-based therapeutics and tumor targeted delivery in ca... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RNAi-based therapeutics and tumor targeted delivery in cancer
    2022 288 citations Göknur Kara, George A. Călin et al. Advanced Drug Delivery Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Göknur Kara Türkiye 11 357 169 124 110 50 20 511
Christian Schmithals Germany 12 313 0.9× 192 1.1× 90 0.7× 68 0.6× 61 1.2× 18 478
Junqiao Zhu China 8 292 0.8× 122 0.7× 94 0.8× 123 1.1× 29 0.6× 10 416
Vera Moura Portugal 11 401 1.1× 93 0.6× 139 1.1× 122 1.1× 87 1.7× 21 522
Rebaz Ahmed United States 8 363 1.0× 163 1.0× 129 1.0× 148 1.3× 56 1.1× 10 544
Minjun Cao China 6 431 1.2× 255 1.5× 215 1.7× 158 1.4× 31 0.6× 8 661
Maneesh Gujrati United States 9 429 1.2× 116 0.7× 110 0.9× 94 0.9× 72 1.4× 10 580
Jiamao Luo China 5 256 0.7× 124 0.7× 100 0.8× 114 1.0× 26 0.5× 7 368
Gülşah Erel‐Akbaba Türkiye 10 235 0.7× 65 0.4× 150 1.2× 183 1.7× 42 0.8× 23 438

Countries citing papers authored by Göknur Kara

Since Specialization
Citations

This map shows the geographic impact of Göknur Kara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Göknur Kara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Göknur Kara more than expected).

Fields of papers citing papers by Göknur Kara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Göknur Kara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Göknur Kara. The network helps show where Göknur Kara may publish in the future.

Co-authorship network of co-authors of Göknur Kara

This figure shows the co-authorship network connecting the top 25 collaborators of Göknur Kara. A scholar is included among the top collaborators of Göknur Kara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Göknur Kara. Göknur Kara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kara, Göknur, et al.. (2024). Abstract 650: Pim3 kinase is a poor prognostic marker and novel molecular target for triple negative breast cancer. Cancer Research. 84(6_Supplement). 650–650. 1 indexed citations
2.
Kara, Göknur & Bülent Özpolat. (2024). SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer. Biomedical Microdevices. 26(1). 16–16. 16 indexed citations
3.
Kara, Göknur & Bülent Özpolat. (2023). Abstract 3786: In vivo miR-449b mimic-based nanotherapy suppresses growth and progression of triple-negative breast cancer. Cancer Research. 83(7_Supplement). 3786–3786. 1 indexed citations
4.
5.
Kara, Göknur, George A. Călin, & Bülent Özpolat. (2022). RNAi-based therapeutics and tumor targeted delivery in cancer. Advanced Drug Delivery Reviews. 182. 114113–114113. 288 indexed citations breakdown →
6.
Kara, Göknur. (2022). siRNA targeting ABCB1 potentiates the efficacy of chemotherapy in human triple-negative breast cancer cells. DergiPark (Istanbul University). 50(4). 349–358. 1 indexed citations
7.
Kara, Göknur, Banu Arun, George A. Călin, & Bülent Özpolat. (2022). miRacle of microRNA-Driven Cancer Nanotherapeutics. Cancers. 14(15). 3818–3818. 24 indexed citations
8.
Önder, Ferah Cömert, Nermin Kahraman, Esen Bellur Atıcı, et al.. (2021). Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo. ACS Pharmacology & Translational Science. 4(2). 926–940. 13 indexed citations
9.
Önder, Ferah Cömert, Nermin Kahraman, Esen Bellur Atıcı, et al.. (2021). Correction to “Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo”. ACS Pharmacology & Translational Science. 4(3). 1247–1247. 2 indexed citations
10.
Kara, Göknur, et al.. (2021). Development of novel poly-l-lysine-modified sericin-coated superparamagnetic iron oxide nanoparticles as siRNA carrier. Colloids and Surfaces A Physicochemical and Engineering Aspects. 630. 127622–127622. 22 indexed citations
11.
Vural, Tayfun, et al.. (2020). Magnetically responsive, sorafenib loaded alginate microspheres for hepatocellular carcinoma treatment. IET Nanobiotechnology. 14(7). 617–622. 12 indexed citations
12.
Kara, Göknur, et al.. (2020). Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy. Colloids and Surfaces B Biointerfaces. 196. 111340–111340. 19 indexed citations
13.
Kara, Göknur, Nermin Kahraman, Emir Baki Denkbaş, George A. Calin, & Bülent Özpolat. (2020). MiR-329 mimic based nano-therapy inhibits growth and progression of triple negative breast cancer. 1 indexed citations
14.
Kara, Göknur, Nermin Kahraman, Emir Baki Denkbaş, George A. Calin, & Bülent Özpolat. (2020). Abstract 5985: MiR-329 mimic based nano-therapy inhibits growth and progression of triple negative breast cancer. Cancer Research. 80(16_Supplement). 5985–5985. 2 indexed citations
15.
Kara, Göknur, Ferda Alpaslan Pınarlı, Güleser Saylam, et al.. (2019). Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment. Preparative Biochemistry & Biotechnology. 49(7). 659–670. 39 indexed citations
16.
Kara, Göknur, et al.. (2019). Designing siRNA-conjugated plant oil-based nanoparticles for gene silencing and cancer therapy. Journal of Microencapsulation. 36(7). 635–648. 9 indexed citations
17.
Bakan, Feray, et al.. (2017). Synthesis and characterization of amino acid-functionalized calcium phosphate nanoparticles for siRNA delivery. Colloids and Surfaces B Biointerfaces. 158. 175–181. 32 indexed citations
18.
Aşık, Mehmet, et al.. (2015). Therapeutic potential of inhibiting ABCE1 and eRF3 genes via siRNA strategy using chitosan nanoparticles in breast cancer cells. Journal of Nanoparticle Research. 17(4). 7 indexed citations
19.
Kara, Göknur, Sema Tuncer, Mustafa Türk, & Emir Baki Denkbaş. (2015). Downregulation of ABCE1 via siRNA affects the sensitivity of A549 cells against chemotherapeutic agents. Medical Oncology. 32(4). 103–103. 11 indexed citations
20.
Baykara, Murat & Göknur Kara. (2014). "In vitro" MRI findings of an agent can be used in the imaging of GABA receptors and similar agent's future projections.. PubMed. 18(18). 2624–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Schmithals Breakdown of academic impact, for papers by Junqiao Zhu Breakdown of academic impact, for papers by Vera Moura Breakdown of academic impact, for papers by Rebaz Ahmed Breakdown of academic impact, for papers by Minjun Cao Breakdown of academic impact, for papers by Maneesh Gujrati Breakdown of academic impact, for papers by Jiamao Luo Breakdown of academic impact, for papers by Gülşah Erel‐Akbaba
Rankless by CCL
2026